sk&f-38393 has been researched along with Cognitive Decline in 6 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
| Excerpt | Relevance | Reference |
|---|---|---|
| "The heroin-evoked increase in premature responses is mimicked by a D1 agonist and prevented by a D1 antagonist or genetic ablation of the D1 receptor gene." | 1.46 | Dopamine D1 and D3 Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice. ( Lai, J; Li, Y; Qiao, X; Wang, Y; Wei, S; Yan, P; Yin, F; Zhang, H; Zhu, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cleal, M | 1 |
| Fontana, BD | 1 |
| Double, M | 1 |
| Mezabrovschi, R | 1 |
| Parcell, L | 1 |
| Redhead, E | 1 |
| Parker, MO | 1 |
| Perreault, ML | 1 |
| Fan, T | 1 |
| Banasikowski, TJ | 1 |
| Grace, AA | 1 |
| George, SR | 1 |
| Zang, X | 1 |
| Cheng, ZY | 1 |
| Sun, Y | 1 |
| Hua, N | 1 |
| Zhu, LH | 1 |
| He, L | 1 |
| Pekcec, A | 1 |
| Schülert, N | 1 |
| Stierstorfer, B | 1 |
| Deiana, S | 1 |
| Dorner-Ciossek, C | 1 |
| Rosenbrock, H | 1 |
| Managò, F | 1 |
| Mereu, M | 1 |
| Mastwal, S | 1 |
| Mastrogiacomo, R | 1 |
| Scheggia, D | 1 |
| Emanuele, M | 1 |
| De Luca, MA | 1 |
| Weinberger, DR | 1 |
| Wang, KH | 1 |
| Papaleo, F | 1 |
| Zhu, Y | 1 |
| Wang, Y | 1 |
| Lai, J | 1 |
| Wei, S | 1 |
| Zhang, H | 1 |
| Yan, P | 1 |
| Li, Y | 1 |
| Qiao, X | 1 |
| Yin, F | 1 |
6 other studies available for sk&f-38393 and Cognitive Decline
| Article | Year |
|---|---|
Dopaminergic modulation of working memory and cognitive flexibility in a zebrafish model of aging-related cognitive decline.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adolescent; Adult; Aged; Aged, 80 and ov | 2021 |
The atypical dopamine receptor agonist SKF 83959 enhances hippocampal and prefrontal cortical neuronal network activity in a rat model of cognitive dysfunction.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cognitive Dysfunction; Disease | 2017 |
The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amyloid beta-Peptides; Amyloid Precursor | 2018 |
Targeting the dopamine D
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Cognition; Cognitive Dys | 2018 |
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Cognitive Dysfunct | 2016 |
Dopamine D1 and D3 Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antibodies; Benzazepines; Benzo | 2017 |